Safe Medicine Act

12/19/2024, 9:07 AM

Summary of Bill HR 5575

The Safe Medicine Act, also known as Bill 118 hr 5575, is a piece of legislation currently being considered by the US Congress. The main goal of this bill is to ensure the safety and effectiveness of prescription medications in the United States.

One key provision of the Safe Medicine Act is the requirement for pharmaceutical companies to conduct thorough testing and clinical trials before bringing a new drug to market. This is intended to prevent harmful or ineffective medications from being prescribed to patients.

Additionally, the bill includes measures to increase transparency in the pharmaceutical industry. This includes requiring drug manufacturers to disclose any potential conflicts of interest and financial ties to healthcare providers. The Safe Medicine Act also aims to improve the monitoring and reporting of adverse reactions to medications. This will help identify any potential safety issues with prescription drugs and allow for swift action to protect patients. Overall, the Safe Medicine Act is focused on promoting the safety and efficacy of prescription medications in the United States. By implementing stricter testing requirements, increasing transparency, and improving monitoring of adverse reactions, this bill seeks to protect the health and well-being of American consumers.

Congressional Summary of HR 5575

Safe Medicine Act

This bill addresses issues related to the manufacture of drugs, including essential medicines.

The Department of Health and Human Services, the Department of Defense, and the Department of Veterans Affairs must jointly develop and implement a strategy to increase the domestic production of essential medicines, medical countermeasures, and critical inputs.

If the Food and Drug Administration determines that a drug or active pharmaceutical ingredient is manufactured in a country that may be producing contaminated drugs or ingredients due to systemic manufacturing-related problems, the labeling for that drug or ingredient must have a boxed warning about the potential for contamination.

For government procurement purposes, the President's authority to waive certain purchasing requirements that discriminate against foreign products may not be used to waive any preferences for goods that are essential medicines, medical countermeasures, or critical inputs.

Read the Full Bill

Formatted TextPDFFormatted XML

Current Status of Bill HR 5575

Bill HR 5575 is currently in the status of Bill Introduced since September 19, 2023. Bill HR 5575 was introduced during Congress 118 and was introduced to the House on September 19, 2023.  Bill HR 5575's most recent activity was Referred to the Subcommittee on Health. as of December 17, 2024

Bipartisan Support of Bill HR 5575

Total Number of Sponsors
2
Democrat Sponsors
0
Republican Sponsors
2
Unaffiliated Sponsors
0
Total Number of Cosponsors
0
Democrat Cosponsors
0
Republican Cosponsors
0
Unaffiliated Cosponsors
0

Policy Area and Potential Impact of Bill HR 5575

Primary Policy Focus

Health

Potential Impact Areas

Cardiovascular and respiratory healthChemical and biological weaponsDrug safety, medical device, and laboratory regulationDrug therapyEmergency medical services and trauma careHealth technology, devices, suppliesInfectious and parasitic diseasesManufacturingMedical tests and diagnostic methodsMilitary medicineMilitary procurement, research, weapons developmentNuclear weaponsPublic contracts and procurementStrategic materials and reservesTrade agreements and negotiationsVeterans' medical careWorker safety and health

Alternate Title(s) of Bill HR 5575

Safe Medicine ActSafe Medicine ActTo direct the Secretaries of Health and Human Services, Defense, and Veterans Affairs to end American over-dependence on Chinese pharmaceuticals by encouraging the growth of a robust domestic medicine supply chain for generic drugs, to empower the Food and Drug Administration to issue boxed warnings in the case of critical contamination, and for other purposes.
Start holding our government accountable!

Comments

Sponsors and Cosponsors of HR 5575

R
Bill Posey
Florida(Republican)

Latest Bills

PROTECT Students Act of 2025
Bill S 994April 4, 2025
A bill to amend the Agriculture Improvement Act of 2018 to reauthorize the feral swine eradication and control pilot program, and for other purposes.
Bill S 1207April 4, 2025
SBA Fraud Enforcement Extension Act
Bill S 1199April 4, 2025
A bill to amend the Internal Revenue Code of 1986 to exclude from gross income certain federally subsidized loan repayments for dental school faculty.
Bill S 1080April 4, 2025
A bill to establish a contracting preference for public buildings that use innovative wood products in the construction of those buildings, and for other purposes.
Bill S 1094April 4, 2025
A bill to amend the Internal Revenue Code of 1986 to exclude from gross income capital gains from the sale of certain farmland property which are reinvested in individual retirement plans.
Bill S 930April 4, 2025
A bill to provide that the Federal Communications Commission may not prevent a State or Federal correctional facility from utilizing jamming equipment, and for other purposes.
Bill S 1137April 4, 2025
A bill to require the heads of Federal agencies to submit to Congress an annual report regarding official time authorized under title 5, United States Code, and for other purposes.
Bill S 1170April 4, 2025
Mining Waste, Fraud, and Abuse Prevention Act of 2025
Bill S 859April 4, 2025
A joint resolution disapproving the rule submitted by the Bureau of Consumer Financial Protection relating to "Defining Larger Participants of a Market for General-Use Digital Consumer Payment Applications".
Bill SJRES 28April 4, 2025